Symptom burden in myeloproliferative neoplasms: clinical correlates, dynamics, and survival impact—a study of 784 patients from the Quebec MPN research group

Symptom burden in myeloproliferative neoplasms: clinical correlates, dynamics, and survival impact—a study of 784 patients from the Quebec MPN research group

Saved in:

Bibliographic Details
Main Authors:	Alisa Poullet, Lambert Busque, Shireen Sirhan, Robert Delage, Ghislain Cournoyer, Ines Chamakhi, Danielle Talbot, Luigina Mollica, Daniele Marceau, Vincent Ethier, Pierre Desjardins, Harold J. Olney, Michaël Harnois, Natasha Szuber
Format:	Article
Language:	English
Published:	Nature Publishing Group 2025-04-01
Series:	Blood Cancer Journal
Online Access:	https://doi.org/10.1038/s41408-025-01234-8
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Elevated Vitamin B12 Levels in Myeloproliferative Neoplasm (MPN) Patients: A Potential Diagnostic and Prognostic Marker
by: Fadul A, et al.
Published: (2024-12-01)

CLASSIFICATION OF MPN
by: Haifa Kathrin Al-Ali
Published: (2025-07-01)

The Hen or the Egg: Inflammatory Aspects of Murine MPN Models
by: Jonas S. Jutzi, et al.
Published: (2015-01-01)

Potential application of the bulk RNA sequencing in routine MPN clinics
by: Shenglong Li, et al.
Published: (2025-04-01)

COVID-19 Vaccinations, Infections, and Outcomes Among 784 People Living with HIV
by: Keren Mahlab-Guri, et al.
Published: (2024-11-01)

MYELODYSPLASTIC/MYELOPROLIFERATIVE DISEASES
by: I. N. Subortseva, et al.
Published: (2017-01-01)

Biology of Myeloproliferative Malignancies
by: AL Melikyan, et al.
Published: (2016-07-01)

Plastic surgery treatment approaches and results for ganglion cysts: retrospective analysis of 1,784 patients
by: Azimet Ozdemir, et al.
Published: (2025-08-01)

Impacto da Nova Lei 14.784/2024 na Pesquisa Clínica em Oncologia
by: Cecilia Ferreira da Silva, et al.
Published: (2024-10-01)

Non-essential role of S100A9 in hematopoiesis in primary MPN and MDS mouse models
by: Qinglin Li, et al.
Published: (2025-07-01)

Plasmablastic Lymphoma in an Immunocompetent Patient with MDS/MPN with Ring Sideroblasts and Thrombocytosis—A Case Report
by: Anthi Bouchla, et al.
Published: (2018-01-01)

The modified asymmetric chondro-perichondrial island graft in type I tympanoplasty: A retrospective analysis of 784 patients
by: Fetih Furkan Şahin, et al.
Published: (2025-03-01)

P784: Novel de novo KAT6A variant in a pediatric patient with multisystem involvement
by: Chaofan Zhang, et al.
Published: (2025-01-01)

I-MPN: inductive message passing network for efficient human-in-the-loop annotation of mobile eye tracking data
by: Hoang H. Le, et al.
Published: (2025-04-01)

Assessing AML-based risk criteria in patients with accelerated/blast-phase MPN treated with less-intensive therapy
by: Reid Shaw, et al.
Published: (2025-05-01)

Detection of Escherichia coli Contamination using Most Probable Number (MPN) methods in Chicken Meats in Market of Surabaya
by: Dhandy Koesoemo Wardhana, et al.
Published: (2021-04-01)

LEITCH, Thomas. (Ed.) The Oxford Handbook of Adaptation Studies. New York: Oxford University Press, 2017, 784 p.
by: Elaine Indrusiak
Published: (2020-01-01)

MPN/MDS OVERLAP SYNDROME ANTICIPATED BY A SEVERE BLEEDING DIATHESIS: HYPOTHESIS OF A PRE-EXISTING PLATELET DISORDER
by: Paola Ranalli, et al.
Published: (2024-08-01)

Mediators of Inflammation in Myeloproliferative Neoplasms: State of the Art
by: Sylvie Hermouet, et al.
Published: (2015-01-01)

Unraveling the impact of lysosomal dysfunction on myeloproliferative neoplasm
by: Hyundong Yoon, et al.
Published: (2024-09-01)

Promising Findings in Myeloproliferative Neoplasms and AL Amyloidosis
by: Axel Rüfer
Published: (2022-10-01)

Defining the Thrombotic Risk in Patients with Myeloproliferative Neoplasms
by: Fabrizio Vianello, et al.
Published: (2011-01-01)

Impact of Inflammation on Myeloproliferative Neoplasm Symptom Development
by: Holly L. Geyer, et al.
Published: (2015-01-01)

VEXAS Syndrome in a Patient with Myeloproliferative Neoplasia
by: Janne Austestad, et al.
Published: (2023-01-01)

Cytokine Regulation of Microenvironmental Cells in Myeloproliferative Neoplasms
by: Gregor Hoermann, et al.
Published: (2015-01-01)

CHRONIC MYELOPROLIFERATIVE NEOPLASMS: A COLLABORATIVE APPROACH
by: Paola Guglielmelli, et al.
Published: (2010-05-01)

MPN-RRT*: A New Method in 3D Urban Path Planning for UAV Integrating Deep Learning and Sampling Optimization
by: Yue Zheng, et al.
Published: (2025-07-01)

A Portable UV-LED/RGB Sensor for Real-Time Bacteriological Water Quality Monitoring Using ML-Based MPN Estimation
by: Andrés Saavedra-Ruiz, et al.
Published: (2025-04-01)

Characteristics of regional epidemiological indicators of chronic myeloproliferative neoplasms
by: O. Yu. Vinogradova, et al.
Published: (2025-05-01)

Failure of Splenectomy to Ameliorate Portal Hypertension in Myeloproliferative Disorders
by: Samuel S Lee, et al.
Published: (1994-01-01)

LANDSCAPE OF SOMATIC MUTATIONS OF MYELOPROLIFERATIVE NEOPLASMS IN PAKISTANI PATIENTS
by: Mehreen Ali Khan
Published: (2025-07-01)

Cerebrovascular Disorders Associated with Ph-Negative Myeloproliferative Diseases
by: MM Tanashyan, et al.
Published: (2019-09-01)

Pathogenesis and management of high molecular risk myeloproliferative neoplasms
by: Victoria Y. Ling, et al.
Published: (2024-12-01)

Miguel Ulloa y Richard T. Hanlin. 2012. Illustrated dictionary of mycology. Second Edition. St. Paul, Minnesota: APS Press. 784 p.
by: María del Carmen A. González-Villaseñor
Published: (2015-05-01)

Anti-cancer activity and cellular uptake of 7,3′,4′- and 7,8,4′-trihydroxyisoflavone in HepG2 cells under hypoxic conditions
by: Wen-Sheng Tzeng, et al.
Published: (2024-12-01)

Myeloproliferative Disease: An Unusual Cause of Raynaud’s Phenomenon and Digital Ischaemia
by: Celia Beynon, et al.
Published: (2016-01-01)

Myeloid sarcoma of the larynx as manifestation of the terminal stage of myeloproliferative disease
by: A. L. Kozhanov, et al.
Published: (2023-06-01)

HMGB1 as a biomarker for myeloproliferative neoplasm complicated with atherosclerosis
by: Lunbi Wu, et al.
Published: (2025-05-01)

Precision Medicine in BCR-ABL1 Negative Myeloproliferative Neoplasms
by: Linet Njue, et al.
Published: (2020-12-01)

Pro- and Antifibrotic Factors in the Serum of Patients with Chronic Myeloproliferative Disorders
by: AA Silyutina, et al.
Published: (2017-10-01)